Data supporting the review article: Efficacy and Safety of Hydroxychloroquine and Chloroquine for Treating COVID-19: A Rapid Review

NOTE: there is no peer-reviewed publication associated with this data record.<br>This data record consists of a single data file <b>Chloroquine or hydroxychloroquine for COVID 19 (1).rm5</b>, in <b>.rm5</b> file format.<br>The file contains the data for forest plots, risk of bias, and summary of findings for the efficacy and safety of hydroxychloroquine and chloroquine.<br><b>Aims and methodology</b>: The related review aimed to determine the efficacy and safety of hydroxychloroquine and chloroquine given as a single drug or in combination with standard care with or without any other antimicrobial agent.The authors searched the PubMed, CENTRAL, Google Scholar, Chinese clinical trial registry, and trial registers: ISRCTN; UMIN-CTR (Japan's Trial Register); the WHO portal up to 9th April 2020 using the search terms *chloroquine, hydroxychloroquine, coronavirus, SARS-Cov-2, 2019-NCov, and COVID-19.For data collection and analysis, the standard Cochrane methods were employed.For more details on the methodology, please read the related article.<br><b>Software needed to access data:</b> The .rm5 file requires the RevMan software to be accessed.<br>